NEUBASE THERAPEUTICS INC (NBSE)

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Monday morning!

What's going on in today's after hours session

Curious about the stocks that are showing activity after the closing bell on Friday?

NeuBase Therapeutics Announces Receipt of Notice from Nasdaq

PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”) today reported that it received a...

Why Is AppTech Payments (APCX) Stock Down 41% Today?

AppTech Payments stock is down on Tuesday after the company priced shares of APCX in a public offering of 2 million units.

Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?

NeuBase Therapeutics stock is down on Tuesday as NBSE investors react to details concerning an upcoming special shareholder meeting.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to dive into the biggest pre-market stock movers on Tuesday as we check out all of the hottest news moving shares this morning!

Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start off Thursday with a breakdown of the biggest pre-market stock movers investors will want to watch this morning.

Symetryx exits stake in NeuBase Therapeutics, shares fall (NASDAQ:NBSE)

NeuBase Therapeutics (NBSE) falls 14% after disclosing that Symetryx has sold its entire position in the biopharmaceutical company.Symetryx sold 203,337 shares in the price range...

NeuBase falls after largest shareholder disposes of part stake (NASDAQ:NBSE)

NeuBase Therapeutics (NBSE) fell ~6% Tuesday noon after the biopharmaceutical company said its largest shareholder Symetryx has disposed of a part of the stake.

NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder

PITTSBURGH, Sept. 08, 2023 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”) today issued the following...